Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft

BACKGROUND: Sorafenib, an oral multikinase inhibitor, has anti-proliferative and anti-angiogenic activities and is therapeutically effective against renal cell carcinoma (RCC). Recently, we have evaluated the tumor responses to sorafenib treatment in a RCC xenograft using [Methyl-(3)H(N)]-3′-fluoro-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ukon, Naoyuki, Zhao, Songji, Yu, Wenwen, Shimizu, Yoichi, Nishijima, Ken-ichi, Kubo, Naoki, Kitagawa, Yoshimasa, Tamaki, Nagara, Higashikawa, Kei, Yasui, Hironobu, Kuge, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153393/
https://www.ncbi.nlm.nih.gov/pubmed/27957722
http://dx.doi.org/10.1186/s13550-016-0246-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153393/
https://www.ncbi.nlm.nih.gov/pubmed/27957722
http://dx.doi.org/10.1186/s13550-016-0246-z

Ejemplares similares